Methods Of Administration Of Thrombopoietin Agonist Compounds

Patent No. EP3127427 (titled "Methods Of Administration Of Thrombopoietin Agonist Compounds") was filed by Novartis on May 27, 2010. The application was issued on Jan 8, 2020.

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

Company	Opposition Date	Representative
TEVA PHARMACEUTICALS	Oct 8, 2020	D YOUNG
ZENTIVA KS	Oct 8, 2020	DENTONS UK AND MIDDLE EAST

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

Date
Description

Get instant alerts for new documents

Aug 25, 2021
Communication to the parties concerning the termination of the opposition proceedings (opponent)
Aug 25, 2021
Communication to the parties concerning the termination of the opposition proceedings (opponent)
Aug 25, 2021
Communication to the parties concerning the termination of the opposition proceedings (proprietor)
May 18, 2021
(Electronic) Receipt
May 18, 2021
Advice of delivery
May 18, 2021
Letter accompanying subsequently filed items
May 13, 2021
Advice of delivery
May 11, 2021
(Electronic) Receipt
May 11, 2021
Advice of delivery
May 11, 2021
Decision revoking the European patent
May 11, 2021
Decision revoking the European patent
May 11, 2021
Decision revoking the European patent
May 11, 2021
Letter accompanying subsequently filed items
May 11, 2021
Transmittal of decision / summons - opposition
May 11, 2021
Transmittal of decision / summons - opposition
May 11, 2021
Transmittal of decision / summons - opposition
May 5, 2021
(Electronic) Receipt
May 5, 2021
Letter accompanying subsequently filed items
May 5, 2021
Request for revocation of patent
Feb 23, 2021
Brief communication - Opposition proceedings
Feb 23, 2021
Brief communication - Opposition proceedings
Feb 23, 2021
Grant of extension of time limit (opposition procedure)
Feb 19, 2021
Communication concerning the filing of a power of attorney
Feb 19, 2021
Communication of amended entries concerning the representative
Feb 8, 2021
(Electronic) Receipt
Feb 8, 2021
Citation in opposition procedure - 024
Feb 8, 2021
Consolidated list of cited opposition documents
Feb 8, 2021
General authorisation
Feb 8, 2021
Letter accompanying subsequently filed items
Feb 8, 2021
Request for extension of time limit
Oct 28, 2020
Communication of a notice of opposition and request to file observations
Oct 28, 2020
Notice of further oppositions to opponent(s)
Oct 28, 2020
Notice of further oppositions to opponent(s)
Oct 20, 2020
Communication of a notice of opposition - first information to patent proprietor
Oct 8, 2020
(Electronic) Receipt
Oct 8, 2020
(Electronic) Receipt
Oct 8, 2020
Citation in opposition procedure - 001
Oct 8, 2020
Citation in opposition procedure - 002
Oct 8, 2020
Citation in opposition procedure - 003
Oct 8, 2020
Citation in opposition procedure - 004
Oct 8, 2020
Citation in opposition procedure - 005
Oct 8, 2020
Citation in opposition procedure - 006
Oct 8, 2020
Citation in opposition procedure - 007
Oct 8, 2020
Citation in opposition procedure - 008
Oct 8, 2020
Citation in opposition procedure - 009
Oct 8, 2020
Citation in opposition procedure - 010
Oct 8, 2020
Citation in opposition procedure - 010
Oct 8, 2020
Citation in opposition procedure - 011
Oct 8, 2020
Citation in opposition procedure - 012
Oct 8, 2020
Citation in opposition procedure - 013
Oct 8, 2020
Citation in opposition procedure - 014
Oct 8, 2020
Citation in opposition procedure - 015
Oct 8, 2020
Citation in opposition procedure - 016
Oct 8, 2020
Citation in opposition procedure - 017
Oct 8, 2020
Citation in opposition procedure - 018
Oct 8, 2020
Citation in opposition procedure - 019
Oct 8, 2020
Citation in opposition procedure - 020
Oct 8, 2020
Citation in opposition procedure - 021
Oct 8, 2020
Citation in opposition procedure - 022
Oct 8, 2020
Citation in opposition procedure - 023
Oct 8, 2020
Non-patent literature cited during the opposition procedure
Oct 8, 2020
Non-patent literature cited during the opposition procedure
Oct 8, 2020
Notice of opposition
Oct 8, 2020
Notice of opposition
Oct 8, 2020
Notice of opposition
Oct 8, 2020
Notice of opposition
Oct 8, 2020
Patent document cited during the opposition procedure
Jan 20, 2020
Transmission of the certificate for a European patent pursuant to Rule 74 EPC
Dec 12, 2019
Decision to grant a European patent
Dec 4, 2019
Decision to allow further processing
Dec 3, 2019
Refund of fees
Dec 3, 2019
Refund of fees
Nov 22, 2019
(Electronic) Receipt
Nov 22, 2019
French translation of claims
Nov 22, 2019
German translation of the claims
Nov 22, 2019
Letter accompanying subsequently filed items
Nov 22, 2019
Request for further processing
Sep 18, 2019
Application deemed to be withdrawn ( translations of claims/payment missing)
Apr 4, 2019
Bibliographic data of the European patent application
Apr 4, 2019
Communication about intention to grant a European patent
Apr 4, 2019
Intention to grant (signatures)
Apr 4, 2019
Text intended for grant
Oct 17, 2018
(Electronic) Receipt
Oct 17, 2018
Amended description with annotations
Oct 17, 2018
Description
Oct 17, 2018
Letter accompanying subsequently filed items
Oct 17, 2018
Reply to communication from the Examining Division
Aug 10, 2018
Grant of extension of time limit (examination procedure)
Aug 7, 2018
(Electronic) Receipt
Aug 7, 2018
Letter accompanying subsequently filed items
Aug 7, 2018
Request for extension of time limit to communication from the Examining Division
Jun 25, 2018
Annex to the communication
Jun 25, 2018
Communication from the Examining Division
Jun 20, 2018
Processing of request for correction of text proposed for grant or third party observations (from 01-04-2012)
May 29, 2018
Processing of request for correction of text proposed for grant or third party observations (from 01-04-2012)
May 24, 2018
(Electronic) Receipt
May 24, 2018
Amended claims with annotations
May 24, 2018
Amended description with annotations
May 24, 2018
Claims
May 24, 2018
Description
May 24, 2018
Letter accompanying subsequently filed items
May 24, 2018
Request for correction/amendment of the text proposed for grant sent from 01.04.2012
Mar 15, 2018
Information about non-relevance of third-party observations
Mar 15, 2018
Processing of request for correction of text proposed for grant or third party observations (from 01-04-2012)
Mar 8, 2018
Transmittal of third party observations to applicant
Mar 5, 2018
Processing of request for correction of text proposed for grant or third party observations (from 01-04-2012)
Mar 1, 2018
Observations by third parties
Feb 16, 2018
Bibliographic data of the European patent application
Feb 16, 2018
Communication about intention to grant a European patent
Feb 16, 2018
Intention to grant (signatures)
Feb 16, 2018
Text intended for grant (clean copy)
Feb 16, 2018
Text intended for grant (version for approval)
Nov 27, 2017
Examination started
Jul 28, 2017
(Electronic) Receipt
Jul 28, 2017
Letter accompanying subsequently filed items
Jul 28, 2017
Letter filed before dispatch of the 1st communication from the Examining Division(examination procedure)
Feb 13, 2017
Reminder period for payment of examination fee/designation fee and correction of deficiencies in Written Opinion/amendment
Jan 11, 2017
Notification of forthcoming publication
Dec 15, 2016
Communication regarding the transmission of the European search report
Dec 15, 2016
European search opinion
Dec 15, 2016
European search report
Dec 15, 2016
Information on Search Strategy
Dec 6, 2016
Search started
Nov 4, 2016
Communication to designated inventor
Nov 4, 2016
Communication to designated inventor
Aug 11, 2016
Abstract
Aug 11, 2016
Acknowledgement of receipt of electronic submission of the request for grant of a European patent
Aug 11, 2016
Claims
Aug 11, 2016
Description
Aug 11, 2016
Designation of inventor
Aug 11, 2016
Request for grant of a European patent
Dec 23, 2010
Priority document (electronically transmitted)

EP3127427

NOVARTIS

Application Number: EP16183711A
Filing Date: May 27, 2010
Status: Revoked; Aug 27, 2021
Publication Date: Jan 8, 2020
External Links: Slate, Register , Google Patents

IP Verse

Methods Of Administration Of Thrombopoietin Agonist Compounds

Patent Summary

Patent Family

Patent Oppositions (2)

Dossier Documents

EP3127427